LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
112.40
-2.12 (-1.85%)
At close: Apr 28, 2026, 4:00 PM EDT
110.22
-2.18 (-1.94%)
After-hours: Apr 28, 2026, 6:30 PM EDT
LeMaitre Vascular Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LeMaitre Vascular stock have an average target of 105.8, with a low estimate of 94 and a high estimate of 118. The average target predicts a decrease of -5.87% from the current stock price of 112.40.
Analyst Consensus: Buy
* Price targets were last updated on Feb 26, 2026.
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | -6.58% | Feb 26, 2026 |
| Roth Capital | Roth Capital | Strong Buy Reiterates $108 → $117 | Strong Buy | Reiterates | $108 → $117 | +4.09% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $87 → $94 | Hold | Maintains | $87 → $94 | -16.37% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $113 → $118 | Buy | Maintains | $113 → $118 | +4.98% | Feb 26, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $95 | Buy | Maintains | $95 | -15.48% | Feb 20, 2026 |
Financial Forecast
Revenue This Year
285.08M
from 249.60M
Increased by 14.21%
Revenue Next Year
310.40M
from 285.08M
Increased by 8.88%
EPS This Year
2.96
from 2.52
Increased by 17.50%
EPS Next Year
3.24
from 2.96
Increased by 9.51%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 298.2M | 331.8M | |||||
| Avg | 285.1M | 310.4M | |||||
| Low | 270.0M | 285.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 19.5% | 16.4% | |||||
| Avg | 14.2% | 8.9% | |||||
| Low | 8.2% | 0.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.20 | 3.57 | ||
| Avg | 2.96 | 3.24 | ||
| Low | 2.75 | 3.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 27.1% | 20.6% | ||
| Avg | 17.5% | 9.5% | ||
| Low | 9.3% | 2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.